Aqua Bio Technology: ABT signs Supply Agreement

Aqua Bio Technology (Oslo Axess : ABT) a Norwegian marine biotech firm developing,
producing and selling patented marine based ingredients and technologies to the
international cosmetic and skin care industry, today announced it has entered into a
sales agreement of with a highly regarded Asian manufacturer of skin care products.

As a part of the agreement, ABT will supply its bioactive ingredient Zonase X(TM) to be
the key ingredient in a new product line the manufacturer will launch in January 2011.
The new line will consist of five products, developed in collaboration with ABT.

The new skin care line will initially be introduced in the Asian markets through the
manufacturer's existing distribution channels. In addition, the manufacturer is also in
discussion with distributors in Australia and selected European countries regarding
launch in those markets.

Due to competitive reasons, the manufacturer has requested that it is not named until
the products are launched. The reason is that the manufacturer considers Zonase X(TM) a
novel and highly innovative technology.

"ABT is very satisfied that we have finalized this Supply Agreement with a highly
regarded manufacturer of skin care products. Since we first signed an NDA in November
2009, we have in close collaboration developed a number of exciting products
demonstrating the wide application of Zonase X(TM)" says Thor A. Talseth, Executive
Chairman of ABT.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

HUG#1447921

ABT signs Supply Agreement http://hugin.info/138686/R/1447921/390405.pdf